SKIN on Nasdaq

SkinHealth Systems Inc.

American surgical and medical instruments and apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with PROCEPT BioRobotics Corp, ANGIODYNAMICS INC or TACTILE SYSTEMS TECHNOLOGY INC, or pick any stock.

  • TickerSKIN on Nasdaq2
  • IndustrySurgical & Medical Instruments & Apparatus2
  • HeadquartersLong Beach, United States2
  • Incorporated inDE3
  • Business address3600 E. Burnett Street, Long Beach, Ca 908153
  • Filer categoryAccelerated filer3
  • Legal formCorporation2
  • LEI5493001Z2JZQT4C63C502
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressc/o CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 32100322

See how the biggest companies compare on our leaderboards

The Beauty Health Company (the “Company” or “we”) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus microneedling and HydraScalp powered by Keravive, the Company combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

65.3%Gross margin5
-6.9%Operating margin5
-3.2%Net margin5
-10.0%Revenue growth, 20255
-15.6%Return on equity5
$37.2MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue35¢$104.4M
  • Research and development2¢$5.6M
  • Other costs62¢$187.2M
  • Income tax1¢$3.6M

Out of $300.8M in revenue.5 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending1¢$303.0K
  • Kept or used elsewhere99¢$37.2M

Out of $37.5M of cash from operations.5

Financial statements

Revenue67895$300.8M in 2025+81% since 2019
0$100.0M$200.0M$300.0M$400.0M2019: $166.6M$166.6M20192020: $119.1M$119.1M2020−29%2021: $260.1M$260.1M2021+118%2022: $365.9M$365.9M2022+41%2023: $398.0M$398.0M2023+9%2024: $334.3M$334.3M2024−16%2025: $300.8M$300.8M2025−10%
Gross profit67895$196.4M in 2025+84% since 2019
0$100.0M$200.0M$300.0M2019: $106.5M$106.5M20192020: $67.2M$67.2M2020−37%2021: $178.5M$178.5M2021+166%2022: $248.8M$248.8M2022+39%2023: $155.1M$155.1M2023−38%2024: $182.3M$182.3M2024+18%2025: $196.4M$196.4M2025+8%
Operating income67895-$20.8M in 2025
-$150.0M-$100.0M-$50.0M0$50.0M2019: $13.5M$13.5M20192020: -$17.2M-$17.2M20202021: -$39.9M-$39.9M2021+132%2022: -$25.8M-$25.8M2022−35%2023: -$130.9M-$130.9M2023+407%2024: -$67.8M-$67.8M2024−48%2025: -$20.8M-$20.8M2025−69%
Net income67895-$9.5M in 2025+481% since 2019
-$400.0M-$200.0M0$200.0M2019: -$1.6M-$1.6M20192020: -$29.2M-$29.2M2020+1681%2021: -$378.8M-$378.8M2021+1198%2022: $44.2M$44.2M20222023: -$100.1M-$100.1M20232024: -$29.1M-$29.1M2024−71%2025: -$9.5M-$9.5M2025−67%
Fiscal year2019202020212022202320242025
Revenue$166.6M6$119.1M7$260.1M8$365.9M9$398.0M5$334.3M5$300.8M5
Cost of revenue$60.1M6$51.9M7$81.5M8$117.1M9$242.9M5$152.0M5$104.4M5
Gross profit$106.5M6$67.2M7$178.5M8$248.8M9$155.1M5$182.3M5$196.4M5
Research and development$4.6M6$3.4M7$8.2M8$8.4M9$10.1M5$6.3M5$5.6M5
Operating expenses$218.5M8$274.6M9$286.0M5$250.1M5$217.2M5
Operating income$13.5M6-$17.2M7-$39.9M8-$25.8M9-$130.9M5-$67.8M5-$20.8M5
Interest$11.8M8$13.4M8$13.6M8
Income before tax-$380.6M8$45.3M9-$101.9M5-$29.6M5-$5.9M5
Income tax-$1.3M6-$9.3M7-$1.9M8$1.1M9-$1.8M5-$452.0K5$3.6M5
Net income-$1.6M6-$29.2M7-$378.8M8$44.2M9-$100.1M5-$29.1M5-$9.5M5
Earnings per share-$0.056-$0.857-$3.718$0.309-$0.765-$0.235-$0.085
Earnings per share (diluted)-$0.056-$0.857-$3.718-$0.239-$0.765-$0.365-$0.165
Shares (weighted, basic)102.1M shares8147.6M shares9131.7M shares5123.8M shares5126.4M shares5
Shares (weighted, diluted)102.1M shares8148.5M shares9131.7M shares5142.5M shares5135.8M shares5

Compare SkinHealth Systems Inc. with another company

Leadership

Who has led SkinHealth Systems Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Brent Saunders2020
  2. Andrew Roy Stanleick2022–2023
  3. Pedro Bruno Ferreira Malha2025–now

Chair

  1. Brent Saunders2020–2021

President

  1. Brent Saunders2020
  2. Indra Pamamull2021–2022
  3. Stephan Becker2021–2022
  4. Pedro Bruno Ferreira Malha2025–now

Chief financial officer

  1. Manisha Narasimhan2020
  2. Liyuan Woo2021–2023

Chief operating officer

  1. Bradley Hauser2023
  2. Sheri Lewis2025–now
2025
Board members and other officers (17)

Former names

  • Beauty Health CoJan 29, 2021 to Apr 20, 20263
  • Vesper Healthcare Acquisition Corp.Aug 12, 2020 to Apr 30, 20213

Timeline

  1. Oct 10, 2025New chief executive Pedro Bruno Ferreira Malha becomes CEO12
  2. Feb 9, 2022New chief executive Andrew Roy Stanleick becomes CEO13
  3. Sep 29, 2020New chief executive Brent Saunders becomes CEO14
  4. Jul 8, 2020Founded SkinHealth Systems Inc. is founded2

Filings

316 filings to the SEC since October 2021: 6 annual reports, 18 quarterly reports, 82 major events, 108 insider forms, 41 large holders, 61 other. The latest 20:

  1. Oct 14, 20268-K EDGAR
  2. Oct 13, 20264 EDGAR
  3. Oct 6, 20268-K EDGAR
  4. Sep 28, 20268-K EDGAR
  5. Sep 10, 20268-K EDGAR
  6. Aug 14, 20268-K EDGAR
  7. Aug 12, 2026DEFA14A ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS EDGAR
  8. Aug 12, 2026DEF 14A DEFINITIVE PROXY STATEMENT EDGAR
  9. Aug 12, 20264 EDGAR
  10. Aug 6, 202610-Q EDGAR
  11. Aug 6, 20268-K EDGAR
  12. Jul 31, 2026PRE 14A PRELIMINARY PROXY STATEMENT EDGAR
  13. Jul 27, 2026SCHEDULE 13G/A EDGAR
  14. Jul 17, 2026SCHEDULE 13G EDGAR
  15. Jul 13, 2026SCHEDULE 13G/A EDGAR
  16. Jul 8, 2026SCHEDULE 13G/A EDGAR
  17. Jun 22, 20268-K EDGAR
  18. Jun 16, 20268-K EDGAR
  19. May 21, 20268-K/A EDGAR
  20. May 20, 2026144 EDGAR

The 316 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

9 open-market trades by officers, directors and large owners since October 2021: 8 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Nov 20, 2024Gruber DesireeDirectorSale14,663$1.50$22.0KForm 4
Aug 12, 2024SAUNDERS BRENT LDirectorBuy40,450$1.08$43.7KForm 4
Aug 17, 2023Miller Brian ChristopherDirectorBuy60,000$5.81$348.6KForm 4
Aug 17, 2023CAPELLAS MICHAEL DDirectorBuy30,000$6.03$180.9KForm 4
Aug 17, 2023MONAHAN MICHAEL P.Chief Financial OfficerBuy5,000$6.02$30.1KForm 4
Aug 17, 2023Stanleick Andrew RoyChief Executive OfficerBuy16,485$6.05$99.7KForm 4
Aug 16, 2023Few JuliusDirectorBuy20,454$6.10$124.8KForm 4
Aug 16, 2023Schillinger Doug K.DirectorBuy33,000$6.11$201.6KForm 4
Aug 16, 2023SAUNDERS BRENT LDirectorBuy59,380$6.10$362.2KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49